Biocon Limited

NSE:BIOCON.NS

338.2 (INR) • At close May 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income 14,29410,2256,4307,7168,4628,70910,0264,5316,88112,2746,2415,3776,1023,9524,471.6893,514.7421,043.5815,386.642,109.9682,025.4892,151.1031,616.711
Depreciation & Amortization 16,87015,68811,1318,1427,1515,5224,4783,8512,7722,4232,2102,0361,7931,7581,567.7471,401.4011,102.519939.204665.482305.999246.841183.593
Deferred Income Tax 001,0341,775-540-522-850-1,185-553-2,697-1,496-1,920-1,261-1,000-1,030.1790000000
Stock Based Compensation 1,3701,0061,3761,2571,0606533283012661296059354.8210000000
Change In Working Capital 9,230-6,352-5,010-7,895-4,238-1,651-291-1,065-2,270-448-3,540377-1,9239802,691.053-345.256-1,282.073171.99-1,280.623-1,491.409-553.561-508.719
Accounts Receivables 5,482-24,17415,905-4,736-2,7881,644-2,243-1,534-1,883-654-1,503-881-198000000000
Inventory -3-8,8648,862-4,140-4,454-3,806-3,052-872-929-582-737227-200-875-509.886-626.21-827.184-176.577-508.35-366.892118.595-377.503
Accounts Payables 029,365-37,3591,6183,1024,0676,083000000000000000
Other Working Capital 3,751-2,6797,582-637-98-3,556-1,079-193-1,341134-2,803150-1,7231,8553,200.939280.954-454.889348.567-772.273-1,124.517-672.156-131.216
Other Non Cash Items -1,1528,9723,564771-298120-2,145188-696-6,417-1,368-322-2-54384.498-164.54786.927-3,320.13923.977-30.191-120.095-5.119
Operating Cash Flow 40,61229,53918,52511,76611,59712,83111,5466,6216,4005,2642,1075,6074,7125,6418,089.6294,406.34950.9543,177.6951,518.804809.8881,724.2881,286.466
Investing Activities:
Investments In Property Plant And Equipment -21,366-19,316-17,263-19,248-17,463-18,365-14,920-9,165-7,621-9,772-9,169-7,985-3,612-2,982-2,399.791-1,864.17-2,955.396-2,325.289-1,906.018-2,284.916-2,850.39-927.735
Acquisitions Net 18,252-5,532-122,171-2,314-1,020-1,7444,029-1,783-1,5375,1421,523336376502-121.552-49.1-724.2742,668.447-163.972000
Purchases Of Investments -102,417-53,340-187,143-77,936-96,992-70,870-53,167-22,816-56,026-37,247-28,710-20,666-21,312-20,208-21,265.555-23,960.298-21,344.346-23,544.098-3,145.113-3,235.869-14,330.518-539.439
Sales Maturities Of Investments 104,08266,464182,49580,25078,48072,61456,12224,50557,26531,67330,78918,59320,68418,56521,104.83723,276.45222,440.03519,588.2453,019.4494,585.95412,204.505368.12
Other Investing Activites -89201,2642,2577482,7767982,4192,934664480341106530255.451336.42262.126211.527204.15746.618129.78318.258
Investing Cash Flow -2,341-10,045-142,818-16,991-36,247-15,589-7,138-6,840-4,985-9,540-5,087-9,381-3,758-3,593-2,426.61-2,260.696-2,321.855-3,401.168-1,991.497-888.213-4,846.62-1,080.796
Financing Activities:
Debt Repayment 5,729-12,712124,1593,21318,888186-1,013-1,141-1,23212,0793,2736,027-43-576-1,739.62810.6852,111.179617.149709.772183.520.36-88.49
Common Stock Issued 10430712,6634288,0705,68131727019399000500000001.2593,150.155
Common Stock Repurchased 00-647-3-93-293-1,009-102-150-15000-13500000000-151.411
Dividends Paid -829-2,030-71800-701-793-7870-2,107-1,200-1,500-1,000-900-700-600-500-300-250-199.27500
Other Financing Activities -23,544-8,892-4,970-1,217-1,225-99781-637-5861,04035-267822-437-305.715-101.97-241.916-84.91150.9388.16482.66632.878
Financing Cash Flow -18,540-23,327130,4872,42125,6403,876-2,417-2,397-1,77510,8671,8624,260-86-1,863-2,745.343-852.0671,369.263232.238510.70246.749-23.0282,943.132
Other Information:
Effect Of Forex Changes On Cash 3122921733715361124-113536534418229856.976-12.37623.524-0.328.7717.5744.4580
Net Change In Cash 20,043-3,8046,411-2,4337231,6542,103-2,612-4736,644-9448301,0501022,974.6521,281.20121.8868.46566.779-14.002-3,140.9023,148.802
Cash At End Of Period 29,2389,19512,9486,5378,9708,2476,5934,4907,10211,2704,6265,5704,7403,6924,373.9041,399.252118.05194.75586.2920.23634.2383,175.14